Research Use of Ecological Momentary Assessment for Adverse Event Monitoring Following Amyloid-β Results Disclosure

Manuscript Number: 

19-0091R2

Author(s): 
Scott R. Beach, Hyejin Kim, William E. Klunk, Melissa Knox, Jennifer H. Lingler, Meghan K. Mattos, Neelesh K. Nadkarni, Lisa S. Parker, J. Scott Roberts, Richard Schulz, Susan M. Sereika, Lisa Tamres

Disclosures

Scott R. Beach

  • Nothing to Disclose

Hyejin Kim

  • Nothing to Disclose

William E. Klunk

  • Consulting Fees:
    Biogen
    Equity:
    Neuroptix stock
    Patents/Royalties
    Patent on Pittsburgh Compound-B related technology

Melissa Knox

  • Nothing to Disclose

Jennifer H. Lingler

  • Consulting Fees:
    Genetech Alzheimer's Disease Clinical Meaningfulness Advisory Board
    Grants
    • Agency: 
      Avid Radiopharmaceuticals
      Dates: 
      2015-2019

Meghan K. Mattos

  • Nothing to Disclose

Neelesh K. Nadkarni

  • Nothing to Disclose

Lisa S. Parker

  • Nothing to Disclose

J. Scott Roberts

  • Nothing to Disclose

Richard Schulz

  • Nothing to Disclose

Susan M. Sereika

  • Nothing to Disclose

Lisa Tamres

  • Nothing to Disclose